Valeant Pharmaceuticals Intl Inc news

   Watch this stock
Showing stories 1 - 10 of about 128   

Articles published

VRX 117.39 -8.44 (-6.71%)
price chart
Valeant Pharmaceuticals International Inc shares pummelled on lower 2014 ...
Canada's Valeant Pharmaceuticals International Inc, embroiled in a bitter battle to take over Botox-maker Allergan Inc, on Thursday cut its 2014 and 2015 profit forecasts, sending shares 10% lower.
Valeant Pharmaceuticals Intl (VRX) Posts Quarterly Earnings Results, Meets ...  WKRB News
Trade-Ideas: Valeant Pharmaceuticals International (VRX) Is Today's Pre ...  TheStreet.com
Related articles »  
Valeant Pharmaceuticals Contacts Quebec and US Regulators About Allergan's ...
LAVAL, Quebec, July 21, 2014 /CNW/ -- Valeant Pharmaceuticals International, Inc. ("Valeant") (NYSE: VRX) (TSX: VRX) has contacted both the Autorite des marches financiers ("AMF") in Quebec and the U.S.
Allergan Inc slahes 13% of its workforce with deep cuts in R&D as it ...  Financial Post
(PR) Valeant Pharmaceuticals Contacts Quebec and US Regulators About ...  Wall Street Journal
Related articles »  
Valeant Pharmaceuticals Completes Sale Of Filler And Toxin Assets To Galderma
LAVAL, Quebec, July 10, 2014 /CNW/ - Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced it has completed the sale to Galderma of all rights to Restylane, Perlane, Emervel, Sculptra, and Dysport owned or held by ...
Related articles »  
Valeant To Report Strong Second-Quarter Earnings And Revenues
Valeant Pharmaceutical Intl Inc. (VRX), will announce financial and operational results for the second quarter of its 2014 (2QFY14) fiscal year on Thursday.
Valeant Pharmaceuticals Submits HSR Filing Relating To Proposed Acquisition ...
LAVAL, Quebec, July 14, 2014 /CNW/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced it has filed a premerger notification under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR) with the U.S.
Valeant Pharma Files Premerger Notification Relating To Allergan Deal  NASDAQ
Related articles »  
September 5th Options Now Available For Valeant Pharmaceuticals ...
Investors in Valeant Pharmaceuticals International Inc (NYSE: VRX) saw new options begin trading today, for the September 5th expiration.
Related articles »  
September 20th Options Now Available For Valeant Pharmaceuticals ...
Investors in Valeant Pharmaceuticals International Inc (NYSE: VRX) saw new options begin trading today, for the September 20th expiration.
Trade-Ideas: Valeant Pharmaceuticals International (VRX) Is Today's ...  TheStreet.com
Related articles »  
Valeant Pharmaceuticals Intl Now Covered by Deutsche Bank (VRX)
Valeant Pharmaceuticals Intl Inc logo Deutsche Bank initiated coverage on shares of Valeant Pharmaceuticals Intl (NYSE:VRX) in a research note released on Tuesday morning, TheFlyOnTheWall.
Correcting an earlier blog post �.  MarketWatch (blog)
Related articles »  
Valeant Pharmaceuticals Intl Now Covered by Analysts at Deutsche Bank (VRX)
Valeant Pharmaceuticals Intl Inc logo Equities research analysts at Deutsche Bank started coverage on shares of Valeant Pharmaceuticals Intl (NYSE:VRX) in a research note issued to investors on Tuesday, TheFlyOnTheWall.
TL Resistance Stocks in News- Juniper Networks, Inc. (NYSE:JNPR), Valeant ...  eMarketsDaily
Valeant Pharmaceuticals Intl Inc (TSE:VRX) Takeover Bid, Seems Expensive  Stixs News
Related articles »  
Drug Delivery: Valeant Pharmaceuticals Intl Inc (NYSE:VRX), Alkermes Plc ...
Valeant Pharmaceuticals International, Inc. (NYSE:VRX) announced that its wholly owned subsidiary, Bausch + Lomb has received 510(k) clearance from the U.S.
Related articles »